198 related articles for article (PubMed ID: 8100573)
1. Proliferating cell nuclear antigen (PCNA) and nucleolar organiser regions in Hodgkin's disease: correlation with morphology.
Freeman J; Kellock DB; Yu CC; Crocker J; Levison DA; Hall PA
J Clin Pathol; 1993 May; 46(5):446-9. PubMed ID: 8100573
[TBL] [Abstract][Full Text] [Related]
2. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.
Smith FG; Murray PG; Crocker J
J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401
[TBL] [Abstract][Full Text] [Related]
3. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
4. Nucleoli and AgNORs in Hodgkin's disease.
Mamaev NN; Medvedeva NV; Shust VF; Markochev AB; Pasternak ND
Mol Pathol; 1997 Jun; 50(3):149-52. PubMed ID: 9292150
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A
Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623
[TBL] [Abstract][Full Text] [Related]
6. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
7. Percentage of proliferating cell nuclear antigen (PCNA)-positive Reed-Sternberg cells in nodular sclerosis Hodgkin's disease.
Kordek R; Biernat W; Niewiadomska H; Kupnicka D; Woźniak L; Domagała W; Osborn M
Patol Pol; 1993; 44(3):129-31. PubMed ID: 7902558
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
9. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
Zhao T; Zhang YL; Li CD
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
[TBL] [Abstract][Full Text] [Related]
10. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
[TBL] [Abstract][Full Text] [Related]
11. [Proliferating cells in Hodgkin's disease].
Schmid C; Isaacson PG
Verh Dtsch Ges Pathol; 1992; 76():151-4. PubMed ID: 1283248
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
[TBL] [Abstract][Full Text] [Related]
13. Localization of proliferating cell nuclear antigen (PCNA/Cyclin) in workshop cases of Hodgkin's disease and non-Hodgkin's lymphoma.
Kamel OW; Warnke RA; Banks PM
Semin Diagn Pathol; 1992 Nov; 9(4):311-4. PubMed ID: 1362284
[TBL] [Abstract][Full Text] [Related]
14. Expression of the proliferating cell nuclear antigen in the different types of Hodgkin's disease.
Hell K; Lorenzen J; Hansmann ML; Fellbaum C; Busch R; Fischer R
Am J Clin Pathol; 1993 May; 99(5):598-603. PubMed ID: 7684186
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity in the malignant cellular blue nevus.
Pich A; Chiusa L; Margaria E; Aloi F
Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma.
Tzankov A; Zimpfer A; Went P; Maurer R; Pileri SA; Geley S; Dirnhofer S
Mod Pathol; 2005 Jan; 18(1):90-6. PubMed ID: 15389259
[TBL] [Abstract][Full Text] [Related]
17. [Which are the proliferating cells in Hodgkin's disease?].
Hell K; Lorenzen J; Hansmann ML; Fellbaum C; Busch R; Fischer R
Verh Dtsch Ges Pathol; 1992; 76():155-8. PubMed ID: 1283249
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and P53 in non-Hodgkin's lymphomas.
Korkolopoulou P; Angelopoulou MK; Kontopidou F; Tsengas A; Patsouris E; Kittas C; Pangalis GA
Leuk Lymphoma; 1998 Aug; 30(5-6):625-36. PubMed ID: 9711925
[TBL] [Abstract][Full Text] [Related]
19. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
Sakr WA; Sarkar FH; Sreepathi P; Drozdowicz S; Crissman JD
Prostate; 1993; 22(2):147-54. PubMed ID: 7681206
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]